カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

糖尿病と妊娠

Diabetes and Pregnancy - Delivering Improved Outcomes

発行 Datamonitor
出版日 2004年06月 商品コード 20753
ページ情報 英文  
価格
こちらの商品の販売は終了いたしました。

当商品の販売は、2011年07月19日を持ちまして終了しました。

原文目次

Introduction

About one in 100 women of childbearing age have diabetes before pregnancy (pre-existing diabetes). Another 3-5% develop diabetes during pregnancy (gestational diabetes). While diabetes poses some risks in pregnancy, advances in healthcare have greatly improved the outlook for these pregnancies. However, untreated or poorly controlled gestational diabetes can seriously harm the fetus.

Scope of this report

  • Review of therapeutic approaches to gestational diabetes mellitus and pre-existing diabetes during pregnancy to protect the health of mother & baby
  • Overview of screening and diagnosis guidelines

Research and analysis highlights

The prevalence of congenital anomalies among children of diabetic women is much higher compared to non-diabetic women. The frequency of malformations correlates with the degree of maternal glycemic control. Their prevalence may be reduced by normalization of blood glucose and the maintenance of normal glycemic control throughout the pregnancy.

Key reasons to read this report

  • Get insight in the current therapeutic approaches used to treat women with gestational and pre-existing diabetes during pregnancy
  • Understand the effect of diabetes in pregnancy outcomes and gauge the impact of diabetic complications in the treatment of pregnant women

ABOUT DATAMONITOR HEALTHCARE

About the Cardiovascular pharmaceutical analysis team

EXECUTIVE SUMMARY

Introduction
Scope and coverage of the Brief
Key findings about the topic

GESTATIONAL DIABETES MELLITUS

Definition
Screening and diagnosis
Prevalence
Pathophysiology
The mother
The fetus
Management of GDM
Antepartum management
Nutrition therapy
Monitoring effectiveness of therapy
Intensification of treatment
Obstetric management
Assessment of fetal wellbeing
Timing and mode of delivery
Management after pregnancy
The mother
The child

MANAGEMENT OF PREGNANT DIABETICS

Preconceptional metabolic control and congenital malformations
Management of pregnant diabetic women without complications
Nutrition recommendations
Exercise
Insulin
Hypoglycemia
Ketosis
Management of pregnant diabetic women with vascular complications
Coronary artery disease
Diabetic nephropathy
Retinopathy

APPENDIX

Bibliography
Disclaimer

List of Tables

Table 1: Diagnostic criteria for GDM
Table 2: Glucose targets for antepartum management of GDM
Table 3: Estimated prevalence of CAD in diabetics in the seven major markets, 2003
Table 4: Estimated prevalence of diabetic nephropathy in the seven major markets, 2003
Table 5: Changes in kidney structure and function in diabetic nephropathy
Table 6: Perinatal outcome of patients with diabetic nephropathy
Table 7: Estimated prevalence of diabetic retinopathy in the seven major markets, 2003

List of Figures

Figure 1: Classification of patients at risk of developing GDM
Figure 2: Recommended screening for patients at risk of developing GDM
Figure 3: White's classification of diabetes in pregnancy
Back to Top